Exscientia plc is a pharmatech that offers end-to-end AI-enabled technologies for target identification, drug candidate design, translational models, and patient selection. Its platform enables the design of candidate drug molecules, as well as provides patients with drug therapies through AI-guided assessment. Exscientia was founded in 2012 and is headquartered in Oxford, UK.
What is Exscientia's quote symbol?
What is the 52 week high and low for Exscientia (NASDAQ: EXAI)?
How much is Exscientia stock worth today?
How much is Exscientia's stock price per share?
What is Exscientia's Market Cap?